Company Overview

Vision: A Solution Partner for the Healthy Coexistence of Humans and Animals.Mission: To empower healthcare professionals and distribution partners globally through innovative bio-technology and total diagnostic solutions.

xDbio is a premier, fully-integrated manufacturer specializing in In-Vitro Diagnostics (IVD). Driven by ceaseless challenges and changes, we have evolved from mastering upstream bio-reagents to developing a comprehensive ecosystem of cutting-edge analytical instruments. Our extensive portfolio encompasses Chemiluminescence (CLIA), Fluorescent Immunoassay (FIA), Fully Automated Dry Chemistry, Coagulation, Auto Hematology, and proprietary AI-empowered Hematology Morphology systems.

Our Promise to PartnersWe do not just manufacture equipment; we forge alliances. As a direct-source manufacturer, we are dedicated to empowering local distributors worldwide. By providing reliable supply chains, absolute quality control from raw materials to finished systems, and comprehensive marketing support, we ensure our partners possess a highly competitive edge in their local human and veterinary diagnostic markets.

SonoXAI

Headquartered in Hongkong, xDbio operates a robust borderless global network fully dedicated to supporting distribution partners worldwide.

Global Production & Research HubsState-of-the-art laboratories and automated production lines guarantee stable capacity scaling and continuous worldwide product supply.

Global Market Footprint90+ Countries

Our diagnostic analyzer & reagent portfolio is trusted by healthcare facilities across North America, Europe, Asia and Latin America.

Core Department Leaders

0 +

[2015] -

Foundation & Core Technology:

Established with a focus on innovative bio-technology. Successfully developed proprietary recombinant antigens and monoclonal antibodies, laying a solid foundation for independent raw material manufacturing.

[2019]

Platform Expansion:

Launched our core Fluorescent Immunoassay (FIA) and Fully Automated Dry Chemistry platforms, rapidly expanding our footprint in both veterinary and human diagnostic markets.

[2023] -

Comprehensive Ecosystem

Achieved comprehensive platform coverage with the introduction of our Advanced Coagulation Testing Systems and Auto Hematology Analyzers, providing a total diagnostic solution.

[2025/Today]

The AI & CLIA Era:

Unveiled the revolutionary AI Hematology Morphology Analyzer and high-throughput Chemiluminescence Immunoassay (CLIA) systems, setting new industry standards for precision and efficiency.

User Intent Recognition

Rigorous End-to-End Quality Management SystemIn the life-changing field of diagnostics, accuracy and reliability are non-negotiable. xDbio implements a rigorous, vertically integrated Quality Management System (QMS) that governs every stage—from raw material synthesis to the final assembly of our AI analyzers.

Natural Language Processing (NLP)

Full Range of Global Medical Device CertificationsISO 13485: Certified comprehensive quality management system specifically for medical devices.CE Marking: Full compliance with European health, safety, and environmental protection standards for our instrument platforms and reagent kits.Additional regional clearances including FDA, NMPA available upon request

Natural and Rich Responses

Closed-Loop Vertical Quality ControlWe independently produce core bio-reagents and raw materials to eliminate third-party dependencies. This closed-loop quality control ensures exceptional lot-to-lot consistency, superior analytical sensitivity, and dependable performance across our Hematology, Chemistry, and Immunoassay systems.

how it worksBuilt on vertically integrated manufacturing for consistent diagnostic performance

Independent Bio-Reagent R&D & Production

In-house development and synthesis of core biological raw materials, removing reliance on external suppliers and securing supply stability.

Full Lifecycle QMS Control

Quality standards enforced throughout reagent production, analyzer assembly, performance verification and finished product release.

Stable Clinical Diagnostic Output

Strict closed-loop testing delivers consistent sensitivity and repeatable results across hematology, dry chemistry and immunoassay testing platforms.

Company Overview

Unleashing advanced IVD biotechnology for reliable human & veterinarydiagnostic solutions

aboutUnleashing advanced IVD biotechnologyfor reliable human & veterinarydiagnostic solutions

Global Reach, Local Empowerment

R&D & Advanced Manufacturing Infrastructure

teamCross-disciplinary leaders:driving innovationin portable diagnostic ultrasound

awardsOur Journey of Innovation

Established with a focus on innovative bio-technology. Successfully developed proprietary recombinant antigens and monoclonal antibodies, laying a solid foundation for independent raw material manufacturing.

Launched our core Fluorescent Immunoassay (FIA) and Fully Automated Dry Chemistry platforms, rapidly expanding our footprint in both veterinary and human diagnostic markets.

Achieved comprehensive platform coverage with the introduction of our Advanced Coagulation Testing Systems and Auto Hematology Analyzers, providing a total diagnostic solution.

Unveiled the revolutionary AI Hematology Morphology Analyzer and high-throughput Chemiluminescence Immunoassay (CLIA) systems, setting new industry standards for precision and efficiency.

featuresUncompromising Quality, Globally Certified

User Intent Recognition

Natural Language Processing (NLP)

Natural and Rich Responses

Independent Bio-Reagent R&D & Production

Full Lifecycle QMS Control

Stable Clinical Diagnostic Output

Call Center

Email

Our Location

Social network

Partnership & Support